Treatment with ezetimibe, which inhibits cholesterol binding/uptake via NPC1L1 (ref. 15), abolished the accumulation of myeloid cells induced with HCD (Fig. 3b). The gene discussed is NPC1L1; the disease is heavy chain disease.